Skip to main content

Early screening of lung function by electrical impedance tomography in people with normal spirometry reveals unrecognized pathological features.

Nature communications2025-01-14PubMed
Total: 80.0Innovation: 8Impact: 8Rigor: 8Citation: 8

Summary

Electrical impedance tomography revealed regional time-constant abnormalities indicative of lung pathology in individuals with normal spirometry. With CT as the reference, EIT-based screening achieved sensitivities of 81.3% (concept phase) and 77.9% (validation phase), highlighting its promise for early detection of subclinical lung dysfunction.

Key Findings

  • In people with normal spirometry, EIT detected abnormal regional time constants consistent with unrecognized pathology.
  • CT-referenced sensitivity was 81.3% in the concept phase and 77.9% in the validation phase; specificity was 50%.
  • The study underscores that spirometry may miss early regional dysfunction measurable by EIT.

Clinical Implications

EIT could complement spirometry to flag high-risk individuals for confirmatory imaging and early intervention, potentially preventing progression to overt disease.

Why It Matters

Introduces a noninvasive, bedside-capable imaging biomarker to detect early regional lung dysfunction before spirometric changes, potentially changing screening paradigms.

Limitations

  • Specificity was modest (50%), and CT confirmation was performed in subsets flagged by EIT or smoking history, introducing selection bias.
  • Cross-sectional design without longitudinal clinical outcomes.

Future Directions

Longitudinal studies linking EIT abnormalities to clinical outcomes, optimization of thresholds, and integration into risk-based screening pathways.

Study Information

Study Type
Cohort (diagnostic)
Research Domain
Diagnosis
Evidence Level
II - Prospective diagnostic evaluation with validation cohort and CT reference.
Study Design
OTHER